North America holds a significant share of the DNA microarray chips market, driven by increasing research and development activities, widespread adoption of molecular diagnostics, and growing demand for genomic testing. The region benefits from well-established healthcare infrastructure, favorable funding for biotechnology research, and continuous technological advancements in genomic analysis...